rs7820807

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000912.5(OPRK1):​c.*2996A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.18 in 152,108 control chromosomes in the GnomAD database, including 3,420 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 3420 hom., cov: 32)
Exomes 𝑓: 0.50 ( 0 hom. )

Consequence

OPRK1
NM_000912.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.751

Publications

7 publications found
Variant links:
Genes affected
OPRK1 (HGNC:8154): (opioid receptor kappa 1) This gene encodes an opioid receptor, which is a member of the 7 transmembrane-spanning G protein-coupled receptor family. It functions as a receptor for endogenous ligands, as well as a receptor for various synthetic opioids. Ligand binding results in inhibition of adenylate cyclase activity and neurotransmitter release. This opioid receptor plays a role in the perception of pain and mediating the hypolocomotor, analgesic and aversive actions of synthetic opioids. Variations in this gene have also been associated with alcohol dependence and opiate addiction. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000912.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000912.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPRK1
NM_000912.5
MANE Select
c.*2996A>G
3_prime_UTR
Exon 4 of 4NP_000903.2
OPRK1
NM_001318497.2
c.*2909A>G
3_prime_UTR
Exon 4 of 4NP_001305426.1A0A5F9ZI09
OPRK1
NM_001282904.2
c.*2996A>G
3_prime_UTR
Exon 5 of 5NP_001269833.1P41145-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPRK1
ENST00000265572.8
TSL:1 MANE Select
c.*2996A>G
3_prime_UTR
Exon 4 of 4ENSP00000265572.3P41145-1
OPRK1
ENST00000673285.2
c.*2909A>G
3_prime_UTR
Exon 4 of 4ENSP00000500765.2A0A5F9ZI09
ENSG00000254687
ENST00000524425.1
TSL:3
n.670+9797T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27358
AN:
151986
Hom.:
3408
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.348
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.231
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.0706
Gnomad SAS
AF:
0.105
Gnomad FIN
AF:
0.0890
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.0958
Gnomad OTH
AF:
0.176
GnomAD4 exome
AF:
0.500
AC:
2
AN:
4
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
2
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.180
AC:
27418
AN:
152104
Hom.:
3420
Cov.:
32
AF XY:
0.179
AC XY:
13307
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.348
AC:
14443
AN:
41452
American (AMR)
AF:
0.231
AC:
3532
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
628
AN:
3472
East Asian (EAS)
AF:
0.0704
AC:
364
AN:
5172
South Asian (SAS)
AF:
0.105
AC:
508
AN:
4828
European-Finnish (FIN)
AF:
0.0890
AC:
944
AN:
10606
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.0958
AC:
6513
AN:
67996
Other (OTH)
AF:
0.176
AC:
373
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1033
2065
3098
4130
5163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.147
Hom.:
785
Bravo
AF:
0.199
Asia WGS
AF:
0.113
AC:
393
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.53
DANN
Benign
0.76
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7820807;
hg19: chr8-54138861;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.